We are accepting applications
for studentships to start in October 2018
Closing date for applications, 4th Jan
Early applications encouraged
Why this programme, and why in Cambridge?
The rapid worldwide increase in the prevalence of obesity and diabetes will have a major adverse impact on health, much of which will result from cardiovascular disease.
This PhD programme recruits 4-5 new students each year, providing opportunities for training in a range of approaches to obesity, diabetes and cardiovascular diseases. We aim to train the scientific leaders of the future, providing a supportive environment in which to learn from world class experts using state of the art facilities.
The programme brings together exceptional expertise available in the University Schools of Clinical Medicine and Biological Sciences with that in Cambridge-based MRC Units and the Wellcome Trust Sanger Institute. Our principal investigators are at the international forefront of their scientific disciplines, and provide breadth of expertise, including studies of cellular and molecular mechanisms, the neuroscience of energy balance, murine and human physiology, vascular biology, genetics, nutrition and population sciences. This puts us in a unique position to undertake cross-disciplinary research with a translational impact on human health.